Oops! Your browser version is not supported by our website.
Please use these following browsers to view this page:
Hovione won the 2023 CDMO Leadership Award across all six categories across all three groups of respondents
Hovione´s pragmatic approach to bridging science with manufacturing is now being leveraged for continuous tableting and it is the key to ultimately providing high quality medicines and the success of your drug product.
Hovione is proud to announce the opening of a state-of-the-art continuous tableting (CT) line at its R&D Center in Lisbon.
Hovione and GEA today announced a strategic collaboration to advance Continuous Tableting.
The agreement furthers Hovione´s ability to bring the benefits of continuous tableting, including reduced time to market and increased supply chain flexibility, to pharmaceutical customers globally
Pharmaceutical Technology, 10 October 2022
Welcome to the future of drug product development
Google Chrome
Safari
Firefox
Edge